Annual Meeting 2023 | Unanticipated Targets: New Evidence that Metformin and SGLT2 Inhibitors Regulate Skeletal Muscle Metabolism

1CEC

Metformin and SGLT2 inhibitors are widely used to treat insulin resistance and type 2 diabetes. However, this course explores new evidence regarding the impact of such drugs on skeletal muscle health and function, including how metformin treatment can regulate myogenesis and mitochondrial function during aging and muscle disuse, new evidence explaining how SGLT2 inhibitors can improve skeletal muscle insulin action, and exploration of whether SGLT2 inhibitor treatment augments or impairs skeletal muscle adaptations to exercise.

Viewpoints presented in these videos reflect opinions of the presenters and do not reflect positions or policies of ACSM.

This course includes an online video from ACSM’s 2023 Annual Meeting and presentation evaluations.

All course content will be presented to you electronically upon completion of your purchase. This includes all videos, evaluations and certificates of completion.

Access to this content is available for 1 year (365 days) from the date of purchase.

Refunds and course substitutions will not be allowed for this bundle.  

For questions related to your online purchases, please email onlinelearning@acsm.org.  

Membership Discount 

Join ACSM and save 50% on CEC quizzes by contacting our membership department at membership@acsm.org.  Membership dues updates may take a minimum of 24 hrs. to be reflected in your account. 

Disclaimer

Care has been taken to confirm the accuracy of the information present and describe generally accepted practices. ACSM expressly disclaims all liability for damages or injury of any kind arising out of information contained in this content.